Nanci Almeida Ribeiro

Mx. Nanci Almeida Ribeiro


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2025 in Agronomy
Verified
Journal Article
Open access
PDF file
VMVANESSA Mattos
VANESSA Mattos
CTCaio A. R. Torres
Caio A. R. Torres
MSMarcilene F. A. Santos
Marcilene F. A. Santos
AGAna C. M. M. Gomes
Ana C. M. M. Gomes
Nanci Almeida RibeiroNanci Almeida Ribeiro
Nanci Almeida Ribeiro
RCRegina Carneiro
Regina Carneiro
Root-knot nematodes (RKNs), Meloidogyne spp., are the most economically important plant parasites with a worldwide distribution and a very wide host spectrum. The use of rhizobacteria for biocontrol has seen a marked increase in recent years, with particular emphasis on members of the Bacillaceae family in Brazil. This work reports on five years of experience using Bacillus-based products as nematicides, including both commercial and experimental formulations. Trials on cotton (200–300 mL/100 kg of seeds) against M. incognita race 3 produced inconsistent results: one trial achieved approximately 50% control, while another showed no significant effect. In soybean, Bacillus-based biological products (200–300 mL/100 kg) were able to reduce the final population of M. javanica and M. incognita by an average of approximately 30%, although in some cases, no effect was observed. The use of different doses of a product containing the RTI 545 strain (B. thuringiensis) resulted in control efficiencies of approximately 60–80% at a dose of 500 mL/100 kg, when applied as a seed treatment in soybean. This dose is too high to employ in field conditions. In tomato crop, strain S2538 of Priestia aryabhattai and strain RTI 545 (150 mL/100 kg) reduced the final population of M. incognita by 45–50%, confirming the results obtained in previous trials. Additionally, microscopic observations of Bacillus spp. against Meloidogyne spp. in soybean were made during histopathological studies. The bacteria were found to colonize root tissues early, including the cortex and vascular cylinder, probably producing chemical compounds and later disrupting giant cells. This microscopic observation suggests a mechanism aligned with induced resistance. Currently, biological products must be used in integrated management, such as resistant varieties, crop rotation, and other agronomic practices that aim to balance the physical, chemical and biological conditions of soils.

27 July 2026 in ACS Infectious Diseases
Verified
Journal Article
Open access
JVJosé Feliciano Brango Vanegas
José Feliciano Brango Vanegas
Elizabete CândidoElizabete Cândido
Elizabete Cândido
JCJuliana Carneiro
Juliana Carneiro
Nanci Almeida RibeiroNanci Almeida Ribeiro
Nanci Almeida Ribeiro
Octavio FrancoOctavio Franco
Octavio Franco
Latin America’s biodiversity accounts for approximately 60% of the world’s total, fueling scientific research into natural products, a highly relevant area in drug discovery to this day. This is accompanied by an increasing number of antimicrobial peptides (AMPs) derived from natural products in the region, which over the past decade have been redesigned through modifications, enhancements, and refinements of their physicochemical properties and antimicrobial potency, using approaches that range from rational design and structure–activity relationship (SAR) studies to artificial intelligence and machine learning methodologies. AMPs and their derivatives represent a vast chemical space with potential for antibacterial, antifungal, antiviral, and antiparasitic therapies, with emerging applications beyond infectious diseases. Over the years, studies have identified these peptides from a wide range of sources, including amphibians, reptiles, invertebrates, and microorganisms from South America, highlighting their diverse biological activities. This raises important questions about whether Latin America is a fertile source of inspiration for the development of AMPs. It also prompts an examination of the region’s historical and ongoing contributions to the field of natural and synthetic AMPs with anti-infective potential. Additionally, it highlights the need to assess the region’s progress in keeping pace with the recent advancements in engineering AMPs to combat resistant bacteria. This mini-review addresses these topics and related issues, exploring Latin America’s discoveries, challenges, and innovations in AMPs and their applications, particularly in anti-infective agents.